4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Bringing the artificial pancreas home (AP@home)
Date du début: 1 févr. 2010, Date de fin: 31 oct. 2014,
Description
In order to improve treatment of diabetes patients at home, the main goal of AP@Home is to build and evaluate an artificial pancreas (AP). The AP will allow automated glucose control: It monitors your blood glucose (sugar) levels and a software algorithm calculates how much insulin to deliver at any time via a built-in insulin in ...
Voir le projet
15
Participants partenaires
TERMINÉ
Personal Glucose Predictive Diabetes Advisor (DIAdvisor)
Date du début: 1 mars 2008, Date de fin: 30 juin 2012,
The DIAdvisor is a large scale integrating project (IP) aiming at development of a prediction based tool which uses past and easily available information to optimise the therapy of type I and developed type II diabetes.The DIAdvisor does not depend on specific sensor technologies and technologies like standard strip sensing, minimally-invasive continuous glucose sensors and non-invasive methods.Fo ...
Voir le projet
13
Participants partenaires
TERMINÉ
Mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics (Mitotarget)
Date du début: 1 févr. 2009, Date de fin: 31 mars 2012,
Mitochondrial dysfunction is a major hallmark of various neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease, Huntington’s diseases or Amyotrophic Lateral Sclerosis (ALS). However linking mitochondrial dysfunction to the pathogenesis of some of these diseases still needs to be elucidated. Furthermore, in pathologies where this link is already established, the question re ...
Voir le projet
19
Participants partenaires
TERMINÉ
Natural course, pathophysiology, models for early diagnosis, prevention and innovative treatment of TNF Receptor Associated Periodic Syndrome TRAPS with application for all hereditary recurrent fevers (EUROTRAPS)
Date du début: 1 avr. 2008, Date de fin: 30 sept. 2011,
The TNF Receptor Associated Syndrome (TRAPS) is a rare disease of innate immunity, caused by mutations in TNFR1. It is characterised by recurrent bouts of fever and pain and mainly affects patients of European ancestry. The development of renal amyloidosis in up to 20% of cases makes it a potentially fatal disease. Corticosteroids and anti-TNF therapeutics have not been consistently effective in c ...
Voir le projet